VOLITIONRX LTD — Director's Dealing 2016

May 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-04

Reporting Person: Faulkes Martin Charles (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-04	Warrant (Right to Buy)	$2.6	D	58034	Disposed	2016-05-10	Common Stock (58034)	Direct
2016-05-04	Warrant (Right to Buy)	$2.6	A	58034	Acquired	2017-05-10	Common Stock (58034)	Direct

Footnotes

F1: The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on May 11, 2012 with an expiration date of May 10, 2016. The warrant expiration date was extended one year to May 10, 2017.